In view of these developments, SPPARγMs with partial agonism in transcriptional activity were found to be advantageous not only as promising candidates for the treatment of T2DM but also as useful chemical probes for the elucidation of the biological function and regulation mechanism of PPARγ. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.